The obesity doctor responds to claims a pharmacist made about GLP-1 medications. Details of the claims aren't given, so tap through to hear his take.
Recap by typeshit. Post by @drnadolsky on Instagram.
The chain says it is exploring concepts including grilled items aimed at GLP-1 users, a sign of how the drugs are shifting food businesses.
Ahead of results, Kalkine looks at how costly late-stage trials for Amgen's monthly obesity shot MariTide weigh on the outlook.
A short post says demand for GLP-1s, psychedelics and testosterone is meeting commercial interests, calling it a big shift.
A beauty take that waves off pricey LA peptide and salmon sperm serums, saying better anti-aging habits are found closer to home.
The listener was on a microdose. Dr. Cole says the scientific literature shows no established link between semaglutide and the finding, per @theartofbeingwell_.
50:48
The DOWNSIZED channel answers a question about when people stay on the same GLP-1 dose. Their view, not medical advice, so check with a doctor.
Loading…